Status:
COMPLETED
THrombo-Embolic Event in Onco-hematology
Lead Sponsor:
Centre Antoine Lacassagne
Conditions:
Neoplasms
Thrombosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) is 1 per 200 cancer patients, about 5 times higher than in the general population. These events are of crucial importan...
Detailed Description
The overall incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) is 1 per 200 cancer patients, about 5 times higher than in the general population. These events are of crucial importan...
Eligibility Criteria
Inclusion
- Patient followed for CAL cancer and admitted to the LTC in the Medicine Department.
- Age\> to 18 years.
- Patient having read the information note and signed the informed consent (including specific consent for genotyping of clotting factors).
- Patient receiving social insurance.
- Weight\> 50kg
- Hemoglobin level\> 7.0 g / dl
Exclusion
- Patient not benefiting as part of his treatment from hospitalization, but admitted on an ambulatory basis.
- Patient whose age is less than 18 years.
- Patient already included in the study.
- Patient considered a vulnerable person; Vulnerable people are defined in Article L1121-5 to -8:
- Pregnant women, parturients and breastfeeding mothers
- Persons deprived of their liberty by a judicial or administrative decision, persons hospitalized without consent under Articles L. 3212-1 and L. 3213-1 who do not fall under the provisions of Article L. 1121-8
- and persons admitted to a health or social institution for purposes other than research
- adults who are legally protected or unable to express their consent
Key Trial Info
Start Date :
September 9 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 9 2022
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT03826043
Start Date
September 9 2019
End Date
September 9 2022
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Antoine Lacassagne
Nice, France, 06189